Influences on screening for chronic diabetes complications in type 1 diabetes.
Screening for the long-term complications of diabetes is a critical component of diabetes management; however, evidence demonstrates that screening rates in diabetes populations are suboptimal. Our objective was to determine the use and predictors of optimal screening behavior, defined as receiving a fasting lipid test, dilated eye exam, spot urine test, foot examination, blood pressure reading, and hemoglobin A1c (HbA1c) in the previous year in a representative cohort of subjects with type 1 diabetes. Data are from the Pittsburgh Epidemiology of Diabetes Complications Study, a prospective cohort study of subjects with childhood onset type 1 diabetes. Data from 325 participants who responded to a survey during 1999-2001 were included in analyses. Reported screening rates were as follows: 87.9% had at least one HbA1c measurement in the past year, 63% had a foot exam, 73.3% had a spot urine test, 81.9% had a dilated eye exam, 93.5% had a blood pressure reading and 68.7% received a fasting lipid profile. Within this group, 37.7% of subjects reported undergoing all five tests (optimal screening). Independent correlates of optimal screening were receiving care from a specialist provider (odds ratio [OR] = 2.4; 95% confidence interval [CI]: 1.4-4.1) and blood glucose monitoring at least weekly (OR = 2.6; 95% CI: 1.1-6.2). These findings indicate that a large proportion of persons with type 1 diabetes are not being screened at the optimal level. Our data indicate that efforts to rectify this should focus on men and those who do not monitor blood glucose, and should involve primary care practitioners.
Dorsey
Rashida R
RR
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. rrd3@pitt.edu
Songer
Thomas J
TJ
Zgibor
Janice C
JC
Orchard
Trevor J
TJ
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D001795:Blood Pressure Determination / Q000706:statistics & numerical data; D003430:Cross-Sectional Studies; D048909:Diabetes Complications / Q000175:diagnosis* / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000175:diagnosis; D003955:Diagnostic Tests, Routine / Q000706:statistics & numerical data; D019468:Disease Management; D005215:Fasting; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006776:Hospitals, Pediatric; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D008875:Middle Aged; D010414:Pennsylvania; D016482:Urinalysis / Q000706:statistics & numerical data; D014787:Vision Tests / Q000706:statistics & numerical data
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D008055:Lipids